心包脂肪与原发性肿瘤影像组学预测临床I期非小细胞肺癌隐匿性N2病变及生存:多中心研究与生物学相关性
这项多中心回顾性研究纳入1662例临床I期非小细胞肺癌患者,基于术前CT提取心包脂肪和原发肿瘤影像组学特征构建混合模型预测隐匿性N2病变,外部测试集1和2的AUC分别为0.921和0.913,且高风险组无复发生存期和总生存期更差。
要点
- 混合模型纳入结节密度、脂肪影像组学评分和肿瘤影像组学评分,外部测试集AUC分别为0.921和0.913。
- 外部测试集1敏感度59.3%、特异度93.1%;外部测试集2敏感度56.2%、特异度95.5%。
- 内部测试集中高风险组较低风险组无复发生存期和总生存期更差(p < .001)。
核心结论
- 包含肿瘤和心包脂肪影像组学的模型在预测隐匿性N2病变方面表现良好,并与生存及RNA和基因表达相关。
研究设计与样本
- 回顾性研究,纳入三家医院1662例临床I期非小细胞肺癌切除术患者,中心1(2016年1月至2022年12月)按6:2:2随机分为训练集、调优集和内部测试集,中心2和3(2019年1月至2023年12月)作为外部测试集。
关键影像表现/征象
- 在术前CT上分割心包脂肪和原发肿瘤以提取影像组学特征并生成肿瘤和脂肪影像组学评分。
- 多变量分析后混合模型纳入结节密度、脂肪影像组学评分和肿瘤影像组学评分。
诊断标准与关键数值
- 混合模型预测隐匿性N2病变在外部测试集1的AUC为0.921,准确率89.7%,敏感度59.3%,特异度93.1%。
- 混合模型预测隐匿性N2病变在外部测试集2的AUC为0.913,准确率91.8%,敏感度56.2%,特异度95.5%。
临床应用与阅片要点
- 模型可帮助指导非小细胞肺癌管理。
- 内部测试集中高风险组较低风险组无复发生存期更差(p < .001)。
- 内部测试集中高风险组较低风险组总生存期更差(p < .001)。
局限性
- 外部测试集无随访数据。
- 生物学机制通过公共影像基因组学数据库中单独一组非小细胞肺癌患者探索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Occult N2 disease significantly affects clinical stage I non-small cell lung cancer (NSCLC) prognosis. Pericardial fat characteristics also have prognostic associations. OBJECTIVE. The purpose of this study was to develop and test a model incorporating pericardial fat and tumor radiomic features on CT for detecting occult N2 disease in clinical stage I NSCLC, explore the model's prognostic role, and investigate its biologic basis through radiogenomics analyses. METHODS. This retrospective study included patients who underwent clinical stage I NSCLC resection at three hospitals (center 1 [January 2016 to December 2022], stratified randomly by a 6:2:2 ratio into training, tuning, and internal test sets; centers 2 and 3 [January 2019 to December 2023], serving as external test sets). Pericardial fat and primary tumors were segmented on preoperative CT to extract radiomic features and generate tumor and fat radiomics scores (rad-scores), respectively. Multivariable analysis was performed to create a hybrid model for predicting occult N2 disease at surgery. Performance was evaluated in external test sets. Associations with recurrence-free survival (RFS) and overall survival (OS) were evaluated using log-rank tests in the internal test set; follow-up data were unavailable in the external test sets. Biologic mechanisms were explored through RNA and gene expression analysis in a separate set of patients with NSCLC obtained from a public radiogenomics database. RESULTS. From the three centers, 1662 patients (mean age, 58.6 years; 663 men, 999 women) were included. After multivariable analysis, the hybrid model included nodule density, fat rad-score, and tumor rad-score. The model had AUC, accuracy, sensitivity, and specificity for occult N2 disease of 0.921, 89.7%, 59.3%, and 93.1% and 0.913, 91.8%, 56.2%, and 95.5% in external test sets 1 and 2, respectively. In the internal test set, high-risk compared with low-risk patients showed worse RFS (p < .001) and OS (p < .001). In 122 patients in radiogenomics analysis, high-risk status was associated with activation of molecular pathways and increased activated dendritic cell and mast cell infiltration. CONCLUSION. A model incorporating tumor and pericardial fat radiomics showed good performance in predicting occult N2 disease as well as associations with survival and with RNA and gene expression. CLINICAL IMPACT. The model could help guide NSCLC management.
引用
- Huang WJ, Xie HB, Liu PP, et al. Pericardial Fat and Primary Tumor Radiomics for Predicting Occult N2 Disease and Survival in Clinical Stage I Non-Small Cell Lung Cancer: Multicenter Study and Biologic Correlation. AJR Am J Roentgenol. 2025. PMID: 40397555. doi:10.2214/AJR.25.32861
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。